- Filed
- Aug 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 12, 2024 | 175.38M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $25.65M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $11.34M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $26.84M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $30.04M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $40.89M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $45.1M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $72.06M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $75.76M |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $13.98M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 175.12M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 175.16M sh |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $6.02M |
| Stockholders Equity restated | Q2 2024 · Jun 30, 2023 | $24.19M |
| Stockholders Equity restated | Q2 2024 · Mar 31, 2023 | $22.4M |
| Stockholders Equity restated | Q2 2024 · Dec 31, 2022 | $22.07M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.01 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.01 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.01 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.01 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $10.66M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $21.8M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $217K |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $375K |
| Net Income restated | Q2 2024 · Jun 30, 2023 | $1.98M |
| Net Income restated | Q2 2024 · Jun 30, 2023 | $2.29M |
| Net Income restated | Q2 2024 · Mar 31, 2023 | $306K |
| Operating Income restated | Q2 2024 · Jun 30, 2023 | $1.82M |
| Operating Income restated | Q2 2024 · Jun 30, 2023 | $2.08M |
| Gross Profit restated | Q2 2024 · Jun 30, 2023 | $12.7M |
| Gross Profit restated | Q2 2024 · Jun 30, 2023 | $24.26M |
| Cost Of Revenue restated | Q2 2024 · Jun 30, 2023 | $7.63M |
| Cost Of Revenue restated | Q2 2024 · Jun 30, 2023 | $15.1M |